Chapter XX: What Every Natural Superwoman Needs to Know About Proactively Preventing & Confronting Breast-Cancer

326 Studies indicate women’s fears of breast cancer far exceed reality: Presentation South Atlantic Association OB/Gyn Boca Raton 2004 Levin.
327 Diet and environmental exposure during pregnancy increase risk of future breast cancer: Trends Endocrinol Metab. 2006 Nov;17(9): 340-8. Hilakivi-Clarke L et al.
327 Prenatal exposure to bisphenol (very common estrogen like chemical) induces breast cancer: Environ Health Perspect. 2007 Jan;115(1):80-6. Durando M et al.; Environ Health Perspect. 2007 Apr;115(4):592-8. Wadia PR et al.
327 Alcohol consumption during pregnancy and risk of future breast cancer in unborn daughter: Br J Cancer. 2004 Jun;1;90(11): 2225-31. Hilakivi-Clarke L et al.
327 High-fat diet and significant weight gain during pregnancy increase rates of breast cancer in offspring: Int J Cancer. 2006 Oct 1;119(7): 1537-46. De Assis S et al.
327 Use of DES increases occurrence of breast cancer in unborn daughters: Cancer epidemiol Biomarkers Prev. 2006 Aug;15(8): 1509-14. Palmer JR et al.
327 Study: adult women who have gained 55 pounds experience increased risk of breast cancer: JAMA. 2006 Jul 12;296(2):193-201. Eliassen AH et al.; Semin Oncol. 2006 Apr;33(2 Suppl 7):2-7. Forbes JF.
328 Birth control significantly increase incidence of breast cancer, risk is much higher if oral contraceptive start at young age: Breast Cancer Res Treat. 1998 Jul;50(2):175-84. Ursin G et al.; J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. White E et al.; Contraception. 1996 Sep;54(3 Suppl):1S-106S. 
328 Teenage pregnancy decreases breast cancer for life: Int J Food Sci Nutr. 1995 Nov;46(4):373-81. Walker AR et al.
328 Gain of more than 22 pounds since menopause increases risk of breast cancer: JAMA. 2006;296: 193-201. Eliassen AH et al.
328 Consumption of bad fat (Omega 6) increase risk of breast cancer: Cancer Causes Control. 2002 Dec;13(10): 883-93. Wirfalt E et al.
328 Red meat increases risk of breast cancer: Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
328 More than 1.5 servings of red meat a day increases risk of breast cancer bt 97%: Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
328 Increased risk of breast cancer by taking birth control between the ages of 15 and 20: Eur J Cancer. 2005;41(15): 2312-20. Jernstrom H et al.
329 Weight and girth gain during pregnancy increases breast cancer risk: J Nutr. 2006 Apr;136(4): 998-1004. De Assis S et al.
329 Waist hip ratio and weight gain over life time increases breast cancer risk: International J of Cancer. 2002;99: (3): 445-52. Friedenreich CM et al.
329 Weight gain of 38 pounds during pregnancy increase breast cancer risk: American Association for Cancer Research meeting 4/9/02 investigator for George Town University.
329 Antibiotic treatment significantly increases risk for breast cancer: JAMA. 2004;291(7): 827-35. Christine M et al.
329 Increased breast cancer risk due to proliferation of abnormal bacteria due to antibiotic treatment: Cancer Res. 2007 Feb 1;67(3): 847-50. Rao VP et al.
329 Certain groups more susceptible to environmental pollutants: Contraception. 1996 Sep;54(3 Suppl):1S-106S.
330 Study: significant stress doubles breast cancer risk: LA Time. Sep 24, 2002 Health section cancer Conference Copenhagen et al. Med Hypotheses. 2007;68(5):1138-43. Gago-Dominguez M et al.; Mol Cell Biochem. 2007 Aug 11; Zweitzig Dr. et al.
330 Job strain increase risk of breast cancer: Epidemiology. 2007 Sug 30; Kuper H et al.
330 Stress history increase recurrence of breast cancer: J Psychosom Res. 2007 Sep;63(3):233-9 Palesh O et al.
330 Stress increases metastasis marker in breast cancer cell: Mol Cell Biochem. 2007 Aug 11; Zweitzig DR et al.
330 Studies demonstrating iodine deficiency increase risk for breast cancer: Trans New York Acad Sciences. 1970;32: 911-47. Eskin BA.; Breast. 2001 Oct;10(5):379-82. Venturis S.; Cancer Causes Control. 2000 Feb;11(2):121-7. Cann SA et al.; Adv Exp Med Biol. 1977;91:293-304. Eskin BA.
330 SSRIs like Prozac, Zolof etc. increase uncommon but aggressive type of breast cancer: Breast Cancer Res Treat. 2005 Dec 2;: 1-10. Chien C et al.
330 It takes 15 years until 2 breast cancer cells reach size of 1 cm: Jpn J Cancer Res. 1990 May;81(5):454-62. Kuroishi t et al.
331 Breast cancer risk drops with each pregnancy by 7%:LANCET. 2002;360(9328): 187-95.
331 Women with breast cancer who get pregnant live longer and have less recurrences comparing to women with breast cancer that do not get pregnant: BMJ. 2007 Jan 27;334(7586):194. Ives A et al.; Ob. Gyn News. 2006 Jul 13: P2. Largillier R.; J Steroid Biochem Mol Biol. 2007 Jul 20; Monteiro R et al.; Cancer. 2003 Sep 15;98(6):1131-40. Mueller BA et al.; Laeknabladid. 2000 July/august;86(7/8):495-498. Birgisson H et al.; Cancer. 1999 Jun 1;85(11):2424-32. Valentgas P et al.
331 Aromatization is the process that converts testosterone to estrogen in the breast: J Br Med J 1998;296(6624)741-3. O’Neill JS et al.
331 Inflammation with increase of TNFk, NFKbeta, IL6/IL12 and COX-2 activity promote aromatization and increase aggressiveness metastasis ability and resistance to treatment of breast cancer: Endocr Relat Cancer. 2005 Jul;12 Suppl 1: S37-46. Zhou Y et al.; Egypt J Immunol. 2004;11(2): 165-70. Hussein MZ et al.; Endocr Relat Cancer. 2006 Jun;13(2): 607-616. Montagut C et al.; Endocrinology. 2005 Nov;146(11): 4917-25. Saitoh M et al.
331 Women who have 7 or more mammograms increase breast cancer risk by 80%: Breast Cancer Res Treat. 2007 Jul 7; Ma H et al.
331 X-ray before age 20 increase breast cancer by 40% in women with cystic breast: Cancer Causes Control. 2002 Oct;13(8):711-8. Hill DA et al.
331 Women that have radiation as treatment for breast cancer have significant increase in heart attack incidence: Radiother Oncol. 2007 Mar;82(3):294-300. Paszat LF et al.
331 Grapefruit intake may increase risk of breast cancer: Br J Cancer. 2007 Jul 10; Monroe KR et al.
331 Women who where exposed to higher dose of DDT at young age has significant risk of increase breast cancer: Los Angeles Times, By Maria Cone. September 30 2007: Chief investigator Cohn BA.
331 Indole-3-carbinol abolish negative affect of DDT on the breast: Acta Biochim Pol. 2007;54(1):113-7. Ociepa-Zawal M et al.
331 Exposure to higher dose of DDT increases breast cancer: J Natl Cancer Inst. 1993 Apr 21;85(8):648-52. Wolff MS et al.
331 Excessive iron increases the risk of breast cancer: Cancer Causes Control. 2007 Dec;18(10):1047-53. Kabat GC et al.; 
331 Genetic risk for increase iron level associated with increase post menopausal breast cancer: Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1784-94. Hong CC et al.
331 HPV virus Epstein-Bar virus and mouse mammary tumor virus may have a role in the development of cancer: Future Microbiol. 2006 Jun;1:33-51. Lawson JS et al.
331 Oxidative stress contribute to the development of breast cancer: Clin Biochem. 2007 Oct;40(15):1129-34. Delimaris I et al.
331 Progesterone and 17 Beta HSD 2 metabolize estradiol to estrone: Breast Cancer. 2006:13(2): 129-36. Sasano H et al.
332 Evening primrose oil (gamma linolenic acid) enhances positive treatment result of women with Her-2/neu expression in breast cancer: J Natl Cancer Inst. 2005 Nov 2:97(21):1611-5. Menendez JA et al.
332 Evening primrose oil (GLA) may be protecting breast cancer metastasis: J Cell Biochem. 2007 May 1;101(10):155-66. Martin TA et al.
332 Flax seed slow breast cancer metastasis by decrease VEGFs:Cancer Lett. 2002 Nov 8;185(1):31-7. Dabrosin C et al.
332 Flax seed inhibit breast cancer and improve tamoxifen treatment: Clin Cancer Res. 2004 Nov 15;10(22):7703-11. Chen J et al.
332 Fish oil protects us from breast cancer: Int J Cancer. 2005 Nov 10;117(3): 340-8. Wu M et al.; Breast Cancer Res Treat. 1995 Jun;34(3): 199-212. Chajes V et al.; Oncol Rep. 2007 Apr;17(4):713-9. Jourdan ML et al.
332 Fish oil and vitamin E decrease breast cancer cell growth:Breast Cancer Res Treat. 1995 Jun;34(3):199-212. Chajes V et al.
332 Perimenopausal women cosuming more Omega-3 and less Omega-6 less likely to develop breast cancer: J Nutr. 2003 May;133(5): 1409-14. Goodstine SL et al.
332 CLA inhibits cell proliferation in cancer cells: Exp Mol Pathol. 2005 Oct;79(2): 118-25. Albright CD et al.
332 Whey and whey acid proteins inhibits proliferation and spread of breast cancer: J Cell Physiol. 2007 May31; Nukumi N et al.; Cancer Lett. 2007 Jul 8;252(1):65-74. Nukumi et al.
333 Soy and soy products decrease breast cancer and decrease breast cancer resistance to treatment: Oncogene. 2005 Apr 7;24(15):2558-67. Kim SO et al.; J Natl Cancer Inst. 2007 Mar 21;99(6):475-86. Touillaud MS et al.; Cancer Res. 2004 Jun 15;64(12):4346-52. Imai Y et al.
333 Consuming ginger may dcrease breast cancer resistance:Oncogene. 2005 Apr 7;24(15): 2558-67. Kim So et al.
333 Curcumin’s anti-inflammatory and anti-tumor affect as significant protection from breast cancer: Mutat Res. 2001 Sep 1;480-481: 243-68. Surh YJ et al.; Anticancer Res. 2005 Sep-Oct;25(5): 3293-302. Ramachandran C et al.; Int J Mol Med. 2007 Sep;20(3):329-35. Poma P et al.; Cancer Res. 2007 Apr 15;67(8):3853-61. Kunnumakkara AB et al.
333 Investigation of green tea as treatment for breast cancer:IDrugs. 2003 Nov: 6(11): 1073-8. Rosengren RJ.
333 Green tea as an anti-inflammatory and COX-2 inhibitor:Mutat Res. 2001 Sep 1;480-481: 243-68. Surh YJ et al.; Int J Cancer. 2005 Feb 10;113(4): 660-9. Hussain T et al.
333 Green tea decreases aggressive nature of cancer cells: Nutr Cancer. 2005;52(1): 66-73. Slivova V et al.
333 Green tea inhibiting destructive effect of Her-2/neu and (EGFR) that are significant risk factor in breast cancer: Clin Cancer Res. 2003 Aug 15;9(9): 3486-91. Masuda M et al.
333 Green tea enhances efficiency of Taxol: Clin Cancer Res. 2003 Aug 15;9(9): 3486-91. Masuda M et al.
333 Taxol standard breast cancer toxic chemotherapy found not to be effective but with patients with HER2:
333 Grape juice, grape seeds, and red wine as aromatase inhibitors for prevention of breast cancer: Ann N Y Acad Sci. 2002;963: 229-38. Chen S.; Cancer Res. 2006 Jun 1;66(11): 5960-7. Kijima I et al.; Breast Cancer Res Treat. 2001 May;67(2): 133-46. Eng ET et al.; Ann N Y Acad Sci. 2002 Jun;963: 239-46. Eng ET et al.
334 Resveratrol is a COX-2 inhibitor: Biofactors. 2004;21(1-4): 33-9. Kundu JK et al.
334 Resveratrol is a NFkB inhibitor: Int J Mol Med. 2006 Jun;17(6): 1069-75. Kim YA et al.
334 Resveratrol regresses tumor formation: Arch Int Med. 1991;151: 75. Henderson BE et al.
334 Resveratrol as a reason for the so-called “French Paradox”:Mol Nutr Food Res. 2005 May;49(5): 452-61. Ulrich S et al.
334 Pomegranates decrease NFkB: Int J Cancer. 2005 Jan 20;113(3): 423-33. Afaq F et al.; Breast Cancer Res Treat. 2002 Feb;71(3): 203-17. Kim ND et al.
334 Pomegranates decrease breast cancer cell proliferation: J Med Food. 2005 Winter;8(4): 469-75. Jeune MA et al.
334 Pomegranate prevents breast cancer cells from developing new blood vessels and progression: Angiogenesis. 2003;6(2): 121-8. Toi M et al.; Eur J Cancer Prev. 2004 Aug;13(4): 345-8. Mehta R et al.
335 Mushrooms that serve as a treatment option for estrogen receptor negative breast cancer: Oncol Rep. 2006 Feb;15(2): 417-23. Gu YH et al.
335 Ganoderma lucidum mushrooms down regulate NFkB inhibit breast cancer: Int J Oncol. 2006 Sep;29(3): 695-703. Jiang J et al.
335 White button mushroom is chemo preventive in breast cancer via anti aromatase activity: J Nutr. 2006 Apr;136(4):998-1004. de Assis S et al.
335 Perimenopausal women consuming more than 30 grams of fiber daily decrease breast cancer: Int J Epidemiol 2007 Apr;36(2):431-8. Cade J et al.
335 2 Metoxyestradiol protect against breast cancer: Circ Res. 2006 Aug 4;99(3): 266-74. Barchiesi F et al.
335 16 Hydroxy esterone increase breast cancer risk: Maturitas. 2006 Apr 20;54(1): 72-7. Seeger H et al.
335 Breast cancer patients have higher levels of 16 Hydroxy esterone: Cancer Epidemiol Biomarkers Prev. 1997;6: 505-9. Kabat GC et al.
335 Breast cancer patients have lower levels of 2 Hydroxy esterone: Epidemiology. 2000 Nov;11(6):635-40. Muti P et al.; Epidemiology. 2006 Jan;17(1):80-8. Kabat GC et al.; Steroids. 2003 Jan;68(1):65-72. Fowke JH et al.
335 DIM supplements increase 2 Hydroxy esterone and may protect from breast cancer: Nutr Cancer. 2004;50(2): 161-7. Dalessandri KM et al.
335 Indol3 Carbinol supplements increase 2 Hydroxy esterone: J Cell Biochem Suppl. 1997;28-29: 111-6. Wong GY et al.; Apoptosis. 2006 May;11(5): 799-812. Moiseeva EP et al.; Oncogene. 2001 May 24;20(23): 2927-36. Chinni SR et al.
335 Indol3 Carbinol reduces epidermal growth factor receptors that usually increase cancer progresion: Apoptosis. 2006 May;11(5): 799-812. Moiseeva EP et al.; Carcinogenesis. 2007 Feb;28(2): 435-45. Moiseeva EP et al.
335 High level of 2 Hydroxyesteron associated with osteoporosis: J Clin Endo Meta. 2005;90(4):2035-2041. Napoli N et al.; J Bone Miner Res. 2000 Dec;15(12):2513-20. Leelawattana R et al.
335 Breast cancer associated with increase bone density:Maturitas. 2006 Oct 16; Hadju P et al.
335 Snips in 1B1 increase 4 OH estrone that increase breast cancer: Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3): 209-216. Goodman MT et al.; Cancer Res. 2000 Jul;60(13):3440-3444. Hanna IH et al.; Endocr Rev. 2000 Feb;21(1):40-54. Liehr JG.; Afr J Reprod Health. 2006 Apr;10(1):13-25. Okobia MN et al.
335 Women with SNP in 1B1 have a 220% increase in risk of breast cancer: Cancer Epidemiol Biomarkers Prev. 2000;9(2):147-150. Zheng W et al.
335 DHEA suppresses production of 4 Hydroxy esterone: Mol Cell Biochem. 1999 Aug;198(1-2) 89-100. Ikegwuonu FI et al.
335 COMT defect increases breast cancer: Cancer Res. 1998;58: 2107-2110. Thompson PA et al.; Cancer Res. 1999;59: 4870-4875. Huang CS et al.; Cancer Res. 1997 Dec 15;57(24):5493-7. Lavigne JA et al.
335 Overweight women with COMT defect have higher risk of breast cancer: Cancer Res. 1998 May 15;58(10):2107-10. Thompson PA et al.; Cancer Res. 1999 Oct 1;59(19):4870-5. Huang CS et al.
335 COMT defect and Folic Acid deficiency are risk for breast cancer: Carcinogenesis. 2001;22(10): 1661-1665. Goodman JE et al.
335 GST protects from pollutants and toxins: Cancer Epidemiol Biomarkers Prev. 2001;10: 229-236. Mitrunen K et al.
335 GST SNP defect increase breast cancer risk by 50%: Cancer Epidemiol Biomarkers Prev. 2001;10: 229-236. Mitrunen K et al.; J Natl Cancer Inst. 1998;90: 512-518. Helzlsouer KJ et al.
335 Combination of SNPs in COMP and GST further increase breast cancer risk: Pharmacogenetics. 2002;12: 67-72. Mitrunen K et al.
335 Uderstanding personal risk of developing breast cancer:Fertil Steril. 2004 Jul;82(1):132-7. Clemens B et al.
335 Hope is aromatase inhibitor and may decrease breast cancer: J Steroid Biochem Mol Biol. 2007 Jul 20; Monteiro R et al.;
336 Sulforaphane (SGS) stop breast cancer growth: Drug Discov Today. 2004 Nov 1;9(21):908. Johnston N.; Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.; Mol Cancer Ther. 2007 Mar;6(3):1013-21. Pledgie-Tracy A et al.; Mol Cells. 2005 Dec 31;20(3):364-70. Kim SJ et al.; Life Sci. 2006 May 22;78(26):3043-50. Thejass P et al.; Vascul Pharmacol. 2007 Feb;46(2):77-84. Jackson SJ et al.;
335 Royal jelly inhibits growth in breast cancer cells: Biosci Biotechnol Biochem. 2007 Jan;71(1): 253-5. Nakaya M et al.
336 Quercetin increases protection from breast cancer: Cancer Biol Ther. 2007 Jan 29;6(1). Dechsupa S et al.
336 Selenium down-regulated estrogen Receptor Alpha expression: Breast Cancer Res Treat. 2005 Aug;92(3): 239-50. Shah YM et al.; J Cell Biochem. 2007 Jan 22; Martin TA et al.
336 Vitamin E Tocotrienol functions as an anti-cancer mechanism in pre-cancer and cancer cells: Exp Biol Med. 2005 Apr;230(4): 235-41. Shah SJ et al.; Asia Pac J Clin Nutr. 2005;14(4): 366-73. Sylvester PW et al.; Ann N Y Acad Sci. 2004 Dec;1031: 143-57. Nesaretnam K et al.; Biochem Biophys Res Commun. 2006 Jul 28;346(2): 447-53. Srivastava JK et al.; Cancer Detect Prev. 2005;29(4): 383-8. Yu FL et al.
337 Vitamin D decreases growth of breast cancer cells: J Steroid Biochem Mol Biol. 2005 Oct;97(1-2): 103-9. Townsend K et al.; J Steroid Biochem Mol Biol. 2003 Feb;84(2-3): 149-57. Wietzke JA et al.; Oncogene. 2000 Oct 19;19(44): 5091-7. Campbell MJ et al.; Acta Pharmacol Sin. 2007 Sep;28(9):1373-82. Welsh J.
337 Co-Enzyme Q10 produces complete and partial remission of breast cancer: Biochem Biophys Res Commun. 1994 Mar 30;199(3): 1504-8. Lockwood K et al.
337 Lycopene is a suppressor of the initiation process of breast cancer: Pharmacogenomics. 2006 Jul;7(5): 663-72. Chalabi N et al.; Toxicol In Vitro. 2007 Mar;21(2):217-23. Fornelli et al.
337 Vitamins B-12 and B-6 decrease incidence of breast cancer:J Natl Cancer Inst. 2003 Mar 5;95(5): 373-80. Zhang SM et al.
338 Physical activity decreases the risk of invasive breast cancer: Cancer Epidmed Biomarkers Prev. 2007 Feb;16(12): 236-43. Sprague BL et al.
338 Physical activity decrease estrogen-Positive progesterone-Negative breast cancer: Arch Intern Med. 2006 Dec 11-25;166(22): 2478-83. Bardia A et al.
338 1991 Harvard University study about wearing bras and increase incidence of breast cancer: Eur J Cancer. 1991 27: 131-5. Hsieh CC et al.
339 Bra use decreases Melatonin: Chronobiol Int. 2000 Nov;176:783-93. Lee YA et al.
339 Large bra cup sizes in young women increase risk of perimenopausal breast cancer: Int J Cancer. 2006 Apr 15;118(8): 2031-4. Kusano AS et al.
339 Bra use for 18-24 hours per day increase breast cancer risk more than 100 fold: Dressed To Kill 1995. Avery Press Singer S et al.
339 Stoping to use bra stop shoulder pain: Clin Endocrinol 2006;64(1)20-8. Enriori PJ et al.
340 Study indicating that bra wear results in future breast sagging: J Hum. Ergol. 1990 Jun; 19(1): 53-62. Ashizawa K et al.
340 Higher incidence of breast cancer in upper, outer quadrant of breast: J Appl Toxicol. 2003 Mar-Apr;23(2): 89-95. Darbre PD.
340 Nearly everything applied to upper, outer quadrant is toxic:Appl Toxicol. 2003 Sep-Oct;23(5): 285-8. Harvey PW.
340 Parabens has been identified in breast cancer tissue: J Appl Toxicol. 2005 Jul-Aug;25(4): 301-9. Pugazhendhi D et al.; J Appl Toxicol. 2004 May-Jun;24(3):167-76. Harvey PW et al.
340 Aluminum in antiperspirants associated with DNA alteration: J Inorg Biochem. 2005 Sep;99(9): 1912-9. Darbre PD.
340 Studies indicating longer use of anything on underarm, the earlier breast cancer diagnosis: Eur J Cancer Prev. 2003 Dec;12(6): 479-85. McGrath KG.
341 Full-term pregnancy and breast feeding decrease incidence of breast cancer: LANCET. 2002;360(9328): 187-95.
341 Pregnancy after breast cancer increase survival and decrease cancer recurrence comparing to breast cancer survivor that did not get pregnant: BMJ. 2007 Jan 27;334(7586):194. Ives A et al.; Cancer. 2003 Sep 15;98(6):1131-40. Mueller BA et al.; Laeknabladid. 2000 July/August;86(7/8):495-498. Birgisson H et al.; Cancer. 1999 Jun1;85(11):2424-32. Velentgas P et al.; Los Angeles Times. 2007 Sept 30;UC Berkley study main investigator. Barbara A Cohn.
341 Teenage pregnancy associated with decreased risk of breast cancer: Int J Food Sci Nutr. 1995 Nov;46(4): 373-81. Walker AR et al.
341 Mice given high doses of estrogen and progesterone at puberty reduced breast cancer by 60%, and eliminated HER-2/neu (HER-2): Breast Cancer Res. 2007 Jan 26;9(1): R12. Rajkumar L et al.
341 Breastfeeding decreases incidence of cancer by 4.3%:LANCET. 2002;360(9328): 187-95.
341 Nipple stimulation releases duct obstruction and free-radicals and may decrease breast cancer: Med Hypotheses. 1991 Dec;36(4): 389-96. Murrell TG.; Breast Cancer Res Treat. 1995 Aug;35(2): 225-9. Murrell TG.
342 Progesterone increases the production of oxitocyn: Breast Cancer Res Treat. 1995 Aug;35L2):225-9. Murrell TG.
342 Dhea and androgen protect from breast cancer: Endocrine Related Cancer. 2006;13:335-355. Labrie F.
342 Dhea and androgens inhibits breast cancer: Endo Review. 2003;24(2)”152-182. Labroe F et al. 
342 Dhea decrease breast cancer proliferation: Cancer J. 2006 Mar-Apr;12(2):160-5. Gayosso V et al.
342 Dhea stop progression of breast cancer: Breast Cancer Res. 2005;7(6):R1132-40. Shilkaitis A et al.
342 Dhea and androgens are chemopreventive and novel cancer anti-proliferative by multiple mechanism: Curr Pharm Des. 2006;12(26):3411-21. Matsuzaki Y et al.
342 Dhea protect from breast cancer: Endo Relat Cancer. 2006 Jun;13(2):335-355. Labrie F.
342 Dhea is chemoprotive against breast cancer: Int J Cancer. 2003 Jun 20;105(3):321-5. Ciolino H et al.
342 Dhea is a treatment option to treating estrogen negative breast cancer: World J Surg. 2007 May;31(5);1041-6. Hardin C et al.
342 Androgen and dhea has inhibitory effect on breast cancer:Cancer Res. 2006 Aug 1;66(15):7775-82. Macedo LF et al.
342 DHEA suppresses and prevents growth of 4 Hydroxy esterone: C Y Mol Cell Biochem. 1999;198(1-2): 89-100. Ikeawuonu FL et al.
342 DHT inhibits growth of breast cancer: Breast Cancer Res. 2005;7(6): R1132-40. Shilkaitis A et al.
342 IGBP-3 inhibits growth of breast cancer: Cancer Res. 2004 Mar 15;64(6):2229-37. Kim HS et al.
342 Melatonin decrease breast cancer growth: J Pineal Res. 2006 May;40(4): 291-6. Martinez-Campa C et al.
342 Melatonin improve survival rates in animals with untreated breast cancer: Mol Cell Biochem. 2005 Oct;278(1-2): 15-20. Saez MC et al.
342 Melatonin causes the regression of breast cancer by behaving as an aromatase inhibitor: Breast Cancer Res Treat. 2005 Dec;94(3): 249-54. Martinez-Campa C et al.
344 Higher estriol levels in pregnancy translate to 58% reduction in future breast cancer: Prospective study of Estrogen during pregnancy risk of Breast Cancer; unpublished studies performed at the Public Health Institute in Oakland and funded by USA Army Medical Research. DAMD 17-99-1-9358 et al.
344 Estriol (E3) protect the development of ovarian cancer: J Endocrinol. 2007 Jun;193(3):421-33. Treeck O et al.
344 Adiponectin protects from breast cancer: J Clin Endocrinol Metab. 2007 Apr;92(4):1510-16. Tworoger SS et al.
345 Use of bioidentical estradiol and progesterone promotes decrease in breast cancer: Int J Cancer. 2005 Apr 10;114(3): 448-54. Fournier A et al.; Gynecol Endocrinol. 2006 Aug;22(8):423-31. Espie M et al.
345 Women with breast cancer given estrogen enjoyed higher survival rates: J Clin Oncol. 1999 May;17(5): 1482-7. Vassilopoulou-Sellin R et al.; Menopause. 2003 Jul-Aug;10(4):277-85. Decker DA et al.
345 Breast cancer surgery during highest level of estradiol enjoys better outcomes: Eur J Surg Oncol. 2001 Mar;27(2): 152-6. Holmberg L et al.
345 Estrogen increases apatosis: J Steroid Biochem Mol Biol. 2000;72(3-4): 89-102. Szelei J et al.
345 Estradiol decreases Interleukin-6: Egypt J Immunol. 2004;11(2): 165-70. Hussein MZ et al.; J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):53-8. Wang Y et al.
345 Estradiol reduces NFkB: Endocr Relat Cancer. 2006 Jun;13(2): 607-616. Montagut C et al.; J Huazhung Univ Sci Technology Med Sci. 2006;26(1): 53-8. Wang Y et al.; Poster Endocrin Society. 2004 Page 334 P2 119. Liu H et al.; Mol Endocrinol. 2007 Oct 11; Nettles KW et al.
345 Estrogen receptor positive breast cancer is less aggressive: J Clinc Oncol. 1998 Sep;16(9): 3115-20. Holi IC et al.
345 Estrogen receptor positive has higher survivol rate:Neoplasma. 1993;40(1): 55-7. Heise E et al.; Int J Cancer. 1994 Nov;59(3): 351-6. Nagai MA et al.
345 Estradiol binds to Estrogen Receptor Beta that decrease breast cancer growth: Endocrinology. 2006 Sep;147(9):4132-50. Zhu BT et al.
345 Estrogens were common treatment against breast cancer:JAMA. 1997;237: 2079-85. Carter AC et al.; Endocrine Therapy In Malignant Disease. 1972;156-158. Stoll BA et al.
346 When conventional treatment fails for breast cancer with anti estrogen drug, adding estrogen can make it work again:Breast. 2005 Sep 29. Jordan VC et al.; World J Surg Oncol. 2006 Jul 11;4: 44. Agrawal A et al.; JAMA. 1997;237: 2079-85. Carter AC et al.; Med Pediats Oncol. 1990;18: 317-20. Boyer MJ et al.
346 Animals supplemented with estradiol, experienced a profound reduction in breast cancer tumor size: J The National Cancer Institute. 2002 Aug;94(15):1173. Jordan VK et al.; Clin Cancer Res. 2001;7:3156-65. Josleen VC et al.
346 Study showing estradiol treatment decreased breast cancer and the ability of it to multiply: Breast Cancer Research 2007 Jan 26. Lakshmanaswamy R et al.
346 Dr. Bush’s summarized 25 years and 50 reports on HRT and ERT and concluded that estrogen treatment is no risk factor for increase breast cancer: Obstet & Gynecol. 2001 Sep;98(3): 498-08. Bush TL et al.
346 Dr. Speroff professor OB/GYN of Oregon University said “HRT treatment is beneficial and make breast cancer cells more differential “: Menopause. 2007 Oct 8; Speroff L.
347 Studies confirm reduction of cancer death with use of HRT: Am J Obstet Gyn. 2002;186: 325-34. Nanda K et al.; Ann Endocrinol (Paris). 2007 Sep;68(4):241-250. Caufriez A. 
347 WHI study’s use of Premarin only show 23% decrease breast cancer: JAMA. 2002 Jul 17;288(3): 321-33. Rossouw JE et al.
347 Harvard University study of use of Premarin alone shows no increase of incidence of breast cancer for 15 years: Cancer epidemiol Biomarkers Prev. 2006 Aug;15(8): 1509-14. Palmer JR et al.
347 Harvard University study shows Premarin-only use saw increase of breast cancer only after 20 years in breast cancer:LANCET. 1997;350(9084): 1047-59.
348 Risk associated with estrogen-only treatment is equal to risk from eating red meat five times a week: Arch Intern Med. 2006 Nov 13;166(20): 2253-9. Cho E et al.
348 Risk of breast cancer associated with estrogen-only is equal to taking 50+ days of antibiotics—45%: JAMA. 2004;291(7): 827-35. Christine M et al.
348 Risk associated with estrogen-only is lower than risk from gaining more than 38 pounds while pregnant: American Association for Cancer Research meeting 4/9/02 investigator for George Town University.
348 With family history of breast cancer, use of HRT decrease of death from breast cancer: Ann Inter Med. 1997;127(11): 75-78. Sellers TA et al.
348 Use of HRT prior to cancer diagnosis leads to be better survival rates and decrease of metastasis: Br J Cancer. 1999 Jul;80(9): 1453-8. Jernstrom H et al.
348 Use of HRT with breast cancer survivor decrease by 50% cancer recurrence comparing to breast cancer survivors that did not take HRT: Women’s Health. 2001 Oct. Desala PJ.; J Reprod Med 2004 Jul;49(7):510-26. Levgur M.
348 Study showing women with breast cancer treated with estrogen had higher survival rates: J Clin Oncol. 1999 May;17(5): 1482-7. Vassilopoulou-Sellin R et al.
348 Additional studies showing increased survival rates with use of estrogen in breast cancer survivors: J Natl cancer Inst. 2005 Apr 6;97(7):533-5. Von Schoultz E et al.; Obstet & Gynecol. 2001 Sep;98(3): 498-08. Bush TL et al.; Am J Obstet Gyn. 2002;186: 325-34. Nanda K et al.
349 study finding estrogen use in breast cancer survivors did not increase the breast cancer recurrence: J Natl Cancer Inst 2005;97(7)533-5. Von Schoultz E et al.
349 Use of HRT to early breast cancer survivor with follow up of more than 30 years show no increase in incidence and recurrence of breast cancer: Am J Obstet Gynecol. 2002 Aug;187(2):289-94. Natrajan PK et al.; Obstet Gynecol. 2007 Jun;109(6):1455. Harkins T.
349 Studies confirming increased survival decrease recurrence of cancer with estrogen use in breast cancer survival: Amer J OBGyn. 2002 Aug;187(2): 289-94. Puthugramam K et al.; Menopause. 2003 Jul-Aug;10(4): 277-85. Decker D et al.
349 Women with breast cancer treated with estrogen has higher survival and decrease recurrence comparing to group of breast cancer survivors not taking estrogen: Menopause. 2003 Jul-Aug;10(4): 277-85. Decker D et al.
349 Study showing bioidentical estradiol and progesterone caused a 10% reduction in breast cancer incidence compared to nonusers: Int J Cancer. 2005 Apr 10;114(3): 448-54. Fournier A et al.
349 French study of bioidentical estradiol and progesterone showed decrease breast cancer in user comparing to non user:Gynecol Endocrinol. 2006 Aug;22(8): 423-31. Espie M et al.
349 Mice with breast similar to women breast treated with bioidentical hormones showed significant reduction in breast cancer formation and progession: Breast Cancer Res. 2007;9(2):102. Rajku MAR et al.
349 The fact that use of bioidentical hormones may prevent breast cancer got notice and positive suggestions: Breast cancer Res. 2007;9(2):102. Jerry DJ
349 Estrogen preventive effect on the breast may be blocked by metabolite of cholesterol 27-Hydroxycholesterol: Mol Endocrinol. 2007 Sep 13; Dusell CD et al..
349 WHI study warnings: Ob.Gyn. News. 2007 Jan 1;42(1): 1. Jancin B et al.
349 Dr. Leon Speroff’s speaking publicly about problems with WHI study, “…diagnostic and selection biases…”: Ob Gyn News October 1, 2006. Dixon BK.
349 The world is embracing the use of estrogen and progesterone and emphasizing the safety of natural hormones comparing to the chemicalize hormones: Ann Endocrinol (Paris). 2007 Sep;68(4):241-250. Caufriez A.; Bull Cancer. 2007 May 1;94(5):469-75. Czernichow C et al.; Med J Aust. 2007 Jun 18;186(12):643-6. MacLennan AH.

Location
Uzzi Reiss, MD
414 Camden Drive, Suite 750
Beverly Hills, CA 90210
Phone: 323-925-7871
Fax: (310) 205-0164
Office Hours

Get in touch

323-925-7871